Back
Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities
Yuko Iwase, Noriyasu Kamei, Mariko Takeda-Morishita
Pharmacol. Pharm. Vol.6 No.3, March 24, 2015  DOI: 10.4236/pp.2015.63020
       (PDF  1378K)     HTML      XML
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
Kan Uchiyama, Hiroko Aiki, Aki Matsumura, Kanako Saruta, Ai Yuasa, Zensho Ito, Shinichiro Takami, Keisuke Saito, Yuichiro Ohtaki, Shizuka Suzuki, Susumu Hayashi, Shigeo Koido, Hiroshi Yoshida, Toshifumi Ohkusa, Masayuki Saruta
Food Nutr. Sci. Vol.9 No.2, February 24, 2018  DOI: 10.4236/fns.2018.92009
       (PDF  661K)     HTML      XML
Fatty Acid Treatment with Pure Omega-3 Eicosapentaenoic Acid Ethyl Ester for Patients with Cardiovascular Diseases: Differences between Branded (EPADEL®) and Generic Products
Michihiro Suwa, Isao Morii, Masaya Kino
Food Nutr. Sci. Vol.11 No.10, October 15, 2020  DOI: 10.4236/fns.2020.1110062
       (PDF  1173K)     HTML      XML
Beneficial n-3 polyunsaturated fatty acid levels and n6:n3 ratios after 4-week EPA + DHA supplementation associated with reduced CRP: A pilot study in healthy young adults
Jodi McDaniel, Emily Ickes, Christopher Holloman
Mod. Res. Inflamm. Vol.2 No.4, October 24, 2013  DOI: 10.4236/mri.2013.24008
       (PDF  414K)     HTML     
Dietary Fats and Oils: Some Evolutionary and Historical Perspectives Concerning Edible Lipids for Human Consumption
Dante Roccisano, Jaliya Kumaratilake, Arthur Saniotis, Maciej Henneberg
Food Nutr. Sci. Vol.7 No.8, July 22, 2016  DOI: 10.4236/fns.2016.78070
       (PDF  974K)     HTML      XML
 
 
Top